Arthur R. Ablin, MD

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
ablin_arthur

Professor Emeritus, Clinical Pediatrics, UCSF

arthur.ablin@ucsf.edu

Phone: (415) 476-3086 (direct), 476-3831 (office)
Box 0106, UCSF
San Francisco, CA 94143-0106


Education

University of Michigan, M.D., 1952

Philadelphia General Hospital, 1952-1953, Internship

University of Michigan, 1953-1954, Resident, Pediatrics

University of California San Francisco, 1954-1955, Resident, Pediatrics

Kinderspital, Zurich, Switzerland, 1955-1956, Fellow, Hematology


Professional Experience

  • 1957-1960
    Clinical Instructor, Pediatrics, University of California San Francisco
  • 1960-1971
    Assistant Clinical Professor, Pediatrics, University of California San Francisco
  • 1971-1977
    Associate Clinical Professor, Pediatrics, University of California San Francisco
  • 1978-1989
    Clinical Professor, Pediatrics, University of California San Francisco
  • 1989-1993
    Professor of Clinical Pediatrics, University of California San Francisco
  • 1993-present
    Professor Emeritus of Clinical Pediatrics, University of California San Francisco

Honors & Awards

  • 1955
    Swiss American Institute of Scientific Exchange Fellowship
  • 1982
    UCSF Distinguished Service Award
  • 1998
    Leukemia Society of America, National Chairman's Award
  • 1998
    UCSF, Gold Headed Cane Society
  • 2001
    UCSF, Chancellors Award for Public Service

Selected Publications

  • Grois N, Barkovich A J, Rosenau W, Ablin A. Central nervous system disease associated with Langerhans' cell histiocytosis. Amer J Pediatr Hem/Onc 15:245-254, 1993.
  • Feusner J, Krailo M, Haas J, Campbell J, Lloyd D, Ablin A. Treatment of pulmonary metastases of initial Stage I hepatoblastoma in childhood. Report from the Children's Cancer Group. Cancer 71:859-64, 1993.
  • Gaynon P, Steinherz P, Bleyer W, Ablin A, Albo V, Finklestein J, Grossman N, Novak L, Pyesmany A, Reaman G, et al. Improved therapy for children with acute lymphoblastic leukemia and unfavorable presenting features: a follow-up report of the Children's Cancer Group Study CCG-106. Journal of Clinical Oncology, 11: 2234-42, 1993.
  • Ablin A. Supportive care of immunocompromised pediatric patients. Current Opinion in Pediatrics, 6; 52-57, 1994.
  • Willis B, Ablin A, Weinberg V, Zoger S, Wara W, Matthay K. Disease course and late sequelae of Langerhans' cell histiocytosis: 25-year experience at the University of California, San Francisco. Journal of Clinical Oncology, 14: 2073-82, 1996.
  • Masera G, Chesler MA. Janovic M, Ablin AR, Arush MW, Breatnach F, MccDowell H, Eden T, Epelman C, Fossati Bellani F. SIOP Working Committee on psychosocial issues in Pediatric Oncology: guidelines for communication of the diagnosis. Medical and Pediatric Oncology 28:382-85, 1997
  • Matthay KK, DeSantes K, Hasegawa B, Huberty J, Hattner RS, Ablin AR, Reynolds CP, Seeger RC, Weinberg K, Price D. Phase I dose escalation of 131I-metaiodobenzylguanidine witwh autologous bone marrow support in refractory neuroblastoma. J of Cl Oncol 16:229-236, 1998
  • Masera G, Spinetta, Jankovic M, Ablin AR, Buchwall I, Van Dongen-Melman, Chesler MA. Guidelines for a therapeutic alliance between families and staff: A report of the SIOP working committee on psychosocial issues in pediatric oncology. Medical and Pediatric Oncol 30:1412-2, 1998
  • Matthay KK, DeSantes K, Hasegawa B, Huberty J, Hattner RS, Ablin AR, Reynolds CP, Seeger RC, Weinberg K, Price D. Phase I dose escalation of 131I-metaiodobenzylguanidine witwh autologous bone marrow support in refractory neuroblastoma. J of Cl Oncol 16:229-236, 1998
  • Masera G, Spinetta, Jankovic M, Ablin AR, Buchwall I, Van Dongen-Melman, Chesler MA. Guidelines for a therapeutic alliance between families and staff: A report of the SIOP working committee on psychosocial issues in pediatric oncology. Medical and Pediatric Oncol 30:1412-2, 1998
  • Matthay KK, DeSantes K, Hasegawa B, Huberty J, Hattner RS, Ablin AR, Reynolds CP, Seeger RC, Weinberg K, Price D. Phase I dose escalation of 131I-metaiodobenzylguanidine with autologous bone marrow support in refractory neuroblastoma. J of Cl Oncol 16:229-236, 1998
  • Cushing B, Giller R, Ablin A, Cohen L, Cullen J, Hawkins E, Heifetz SA, Krailo M, Lauer SJ, Marina N, Rao PV, Rescoria F, Vinocur CD, Weetman RM, Castleberry RP. Surgical resection alone is effective treatment for ovarian immature teratoma in children and adolescents: a report of the pediatric oncology group and the children1s cancer group. Am J Obstet Gynecol. 181:353-358, 1999
  • Marina NM, Cushing B, Giller R, Cohen L, Lauer S, Ablin A, Weetman R, Cullen J, Krailo M, Castleberry R. Complete Surgical Excision is Effective Treatment for Children with Immature Teratomas with or without Malignant Elements: A Pediatric Oncology Group/Children1s Cancer Group Intergroup Study. J Clin Oncol 17:2137-2143, 1999
  • Schatz J, Kramer JH, Ablin A, Matthay KK. Processing speed, working memory and IQ: a developmental model of cognition defects following cranial radiation therapy. Neuropsychology 14:189-200, 2000
  • Chapters
  • Ablin A, Isaacs H. Germ Cell Tumors. In: Principals and Practice of Pediatric Oncology. Eds: Pizzo P and Poplock D. Second edition p 867-887, 1992. Lippincott, Philadelphia.
  • Ablin, A and Dollinger M. Childhood Cancers: Soft Tissue amd Bone Sarcomas In: Everyones Guide to Cancer Therapy Eds: Dollinger M, Rosenbaum E and Cable G. Sommerville House Book, Kansas City 2001
  • Ablin A. Special Needs for Supportive Care for Children with Cancer. In: Cancer Medicine Eds: Holland J, Frei E, Bast R et al. Williams and Wilkins, Baltimore p 2927-39, 1997
  • Ablin A. Caring for Children Dying from Chronic Disease. In: Rudolphs Pediatrics 21st Ed Eds: Rudolph A, Hoffman J, Rudolph C McGraw-Hill, Philadelphia in press 2002
  • Books
  • Supportive Care of Children with Cancer: Current Therapy and Guidelines from the Children's Cancer Group. Ed: Ablin A. The Johns Hopkins University Press, Baltimore, 1997.
  • Ibid, Second Edition 1997.